Currently browsing "Life Sciences"
-
The 3 Q’s in Computer System Validation: A Comprehensive Guide to IQ, OQ, and PQ
Computer System Validation: Executive Summary Computer System Validation (CSV) represents one of the most critical regulatory requirements facing FDA-regulated industries today. In an increasingly digital landscape where pharmaceutical manufacturing, clinical trials, and medical device development rely heavily on computerized systems, the stakes for proper validation have never been higher. At the heart of CSV lies […]
-
Exploring Innovative Solutions and Trends for Electronic Records and Signatures
In the fast-evolving world of life sciences, maintaining compliance with regulations is a perpetual challenge. One such pivotal regulation, 21 CFR Part 11, shapes the electronic records and signatures landscape for pharmaceutical, biotechnology, and medical device industries. In a newly released whitepaper, “Navigating 21 CFR Part 11: Solutions for Current Challenges and Future Trends,” organizations […]
-
21 CFR Part 11 Compliance in the Pharmaceutical Industry
The pharmaceutical industry operates in a highly regulated environment to ensure the safety and efficacy of drugs. Central to this regulatory framework is 21 CFR Part 11 compliance, a critical aspect that pharmaceutical companies must prioritize. Code of Federal Regulations (CFR) sets the guidelines and standards that companies in the industry must adhere to, making […]
-
An In-Depth Analysis of FDA 21 CFR Part 211 Compliance in Drug Manufacturing
The pharmaceutical industry is a highly regulated sector where the standard of quality is most critical and must be adhered to. One of the key regulatory frameworks governing pharma manufacturing is the FDA 21 CFR Part 211, which outlines Current Good Manufacturing Practice (cGMP) for Finished Pharmaceuticals. This set of regulations is crucial to maintaining […]
-
Ensuring Data Integrity: A Comprehensive Guide to GxP Compliance in Regulated Industries
In the rapidly evolving landscape of life sciences and regulated industries, adherence to Good Practices (GxP) standards is critical to ensuring the safety, efficacy, and quality of products and services. Among the important parts of GxP compliance are 21 CFR Part 11 and EU Annex 11, guiding principles for electronic records, electronic signatures, and computerized […]
-
Understanding the Distinction Between Quality Assurance and Quality Control: Why It Matters
Introduction: In this article, we will examine two key aspects of quality management: quality assurance and quality control. These are two broad approaches that businesses use to ensure that their products or services meet the needs and expectations of customers. Quality assurance involves building quality into the business processes and operations to ensure that high-quality […]
-
Research, Testing, and Medical Laboratories: 21 CFR Part 11 Compliance
Laboratories in the field of life sciences play an essential role in research, testing, and product development for medical devices and drugs of all kinds. Without them, the medical supply chain would find itself severely constrained, and developing, making, and distributing the life-saving drugs and devices consumers need would be in jeopardy. There’s a lot […]
-
A Sales LMS Can Help Your Pharmaceutical Reps Thrive. Here’s How.
A large portion of the success of the pharmaceutical industry revolves around successful sales. Without good sales reps, the industry like other would easily falter. But selling pharmaceuticals can be a difficult and demanding job, and without proper training, tips, and guidance, most reps will struggle to be successful. Fortunately, a validated learning management system […]
-
Medical Device Companies and 21 CFR Part 11 Compliance
The regulations from the US Food and Drug Administration (FDA) that apply to how various life sciences companies handle electronic files and electronic signatures is known as 21 CFR Part 11. One category of companies that must pay special attention to these regulations are those that manufacture and sell medical devices. But medical device companies […]
-
Biopharmaceutical Research and 21 CFR Part 11 Compliance
Whether a biopharmaceutical organization is large or small, research is essential to moving industry knowledge forward and achieving the organization’s mission. Does biopharmaceutical research fall under the scope of the United States Food and Drug Administration (FDA) 21 CFR Part 11 compliance? The answer is yes if the research site owns, controls, or uses any […]
-
Life Sciences Companies and 21 CFR Part 11 Compliance
In the digital age of the twenty-first century, it’s only natural for all kinds of companies to handle more and more of their business operations digitally. While this process of digitization marches forward, it comes with risks concerning the security of electronic records. For life sciences companies, the United States Food and Drug Administration (FDA) […]
-
Decoding 21 CFR Part 11 – 10 Steps to Achieving Compliance
What is 21 CFR Part 11? 21 CFR Part 11 establishes FDA regulations on Electronic Records & Electronic Signature (ERES), which includes electronic submissions to the FDA. 21 CFR Part 11 defines the criteria under which ERES is considered Trustworthy, Reliable, and Equivalent to paper records. Title 21 is the portion of the Code of […]
